Cargando…
Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
Malignant meningiomas have a high mortality rate and short survival time and currently have no effective treatment. In our study, proteomics analysis was performed to identify highly expressed proteins as therapeutic targets in malignant meningiomas. Cell Counting Kit-8 (CCK-8) assays were performed...
Autores principales: | Hu, Boyi, Hao, Shuyu, Miao, Yazhou, Deng, Yuxuan, Wang, Jing, Wan, Hong, Zhang, Shaodong, Ji, Nan, Feng, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530036/ https://www.ncbi.nlm.nih.gov/pubmed/36203966 http://dx.doi.org/10.3389/pore.2022.1610572 |
Ejemplares similares
-
A Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, Suppresses the Growth of Anaplastic Meningiomas and Inhibits Immune Checkpoint Expression by Regulating STAT1
por: Deng, Yuxuan, et al.
Publicado: (2022) -
Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy by the Biological Macromolecule Nocardia rubra Cell-Wall Skeleton
por: Wu, Jie, et al.
Publicado: (2022) -
Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors
por: Wang, Hao, et al.
Publicado: (2022) -
Potential predictors of immunotherapy in small cell lung cancer
por: Skopelidou, Valeria, et al.
Publicado: (2023) -
Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)